How tirapazamine helps cisplatin work better in cancer treatment
Author Information
Author(s): Kovacs M S, Hocking D J, Evans J W, Siim B G, Wouters B G, Brown J M
Primary Institution: Cancer Biology Research Laboratory, Department of Radiation Oncology, Stanford, CA, USA
Hypothesis
The study investigates how tirapazamine enhances the effectiveness of cisplatin in treating tumors under low oxygen conditions.
Conclusion
Tirapazamine enhances the effectiveness of cisplatin in cancer treatment by increasing DNA damage in tumor cells under low oxygen conditions.
Supporting Evidence
- Tirapazamine is activated in low oxygen levels typical of solid tumors.
- It has been shown to enhance the anti-tumor efficacy of cisplatin without increasing systemic toxicity.
- The potentiation of cisplatin cytotoxicity requires oxygen concentrations below 1%.
- The interaction does not occur in cells with mutations in the ERCC4 protein.
Takeaway
Tirapazamine is a drug that works better when there's less oxygen, helping another cancer drug, cisplatin, to be more effective against tumors.
Methodology
The study involved in vitro experiments to assess the interaction between tirapazamine and cisplatin under hypoxic conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website